Rolf Morgan Skarin
Directeur/Membre du Conseil chez Cereduce AB
Profil
Rolf Morgan Skarin is currently the Director at Cereduce AB and the Vice President at Encubator AB.
Previously, he worked as the Director at Termino C 106 AB and as the Director at SenCere Medical AB.
Postes actifs de Rolf Morgan Skarin
| Sociétés | Poste | Début |
|---|---|---|
Cereduce AB
 Cereduce AB Miscellaneous Commercial ServicesCommercial Services Cereduce AB develops and offers improvement of yeast strains for the fermentation industry. It provides enzyme, chemical, and feed manufacturers with tools. The company was founded by Nils Fredrik Alexander Weschke in 2010 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | 02/06/2011 |
Encubator AB
 Encubator AB Investment ManagersFinance Part of Chalmers University of Technology Foundation, Encubator AB is an alternative investment manager. The company is based in Gothenburg, Sweden. The Swedish company was founded in 2004. The CEO is Jonas Berggren. | Corporate Officer/Principal | - |
Anciens postes connus de Rolf Morgan Skarin
| Sociétés | Poste | Fin |
|---|---|---|
SenCere Medical AB
 SenCere Medical AB Medical SpecialtiesHealth Technology SenCere Medical is working to prevent the occurrence of pressure ulcers by providing innovative medical devices. SenCere's product development is based on its own clinical research in which the physiological mechanisms of pressure ulcer formation are studied, and the results are used to develop a relief alarm, currently under development. SenCere has completed development of their product, SitSafe. First field test are performed during 2011. SenCere's relief alarm aims to help patients and caregivers prevent the occurrence of pressure ulcers. The company SenCere was founded in 2008 after having been started as a business development project at the Göteborg International Bioscience Business School in 2007. The business was based on an idea and a dissertation made at the then Department of Biomedicine and Surgery at Hälsouniversitetet (the University of Health), and the collaboration between Göteborg and Linköping that emerged. SenCere has evolved from a research project to a company within the Sahlgrenska Science Park incubator. SenCere enters an exciting phase where the company is commencing pilot tests of their prototype with potential customers. The first commercial sale is expected to occur within one year to existing contacts in the health care system. | Directeur/Membre du Conseil | - |
Termino C 106 AB
 Termino C 106 AB Industrial SpecialtiesProcess Industries Termino C 106 AB offers a unique microencapsulation technique for controlled release that can be optimized to meet customer needs. Many different substances can be encapsulated and the microcapsules can be designed for different release profiles. It currently specializes in encapsulating biocides mainly for use in water based paints to protect from mold and fungi attacks. The technology has its origin from Chalmers University of Technology in Sweden and the company started as a project at Gothenburg International Bioscience Business School (GIBBS). | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Termino C 106 AB
Termino C 106 AB Industrial SpecialtiesProcess Industries Termino C 106 AB offers a unique microencapsulation technique for controlled release that can be optimized to meet customer needs. Many different substances can be encapsulated and the microcapsules can be designed for different release profiles. It currently specializes in encapsulating biocides mainly for use in water based paints to protect from mold and fungi attacks. The technology has its origin from Chalmers University of Technology in Sweden and the company started as a project at Gothenburg International Bioscience Business School (GIBBS). | Process Industries |
Cereduce AB
Cereduce AB Miscellaneous Commercial ServicesCommercial Services Cereduce AB develops and offers improvement of yeast strains for the fermentation industry. It provides enzyme, chemical, and feed manufacturers with tools. The company was founded by Nils Fredrik Alexander Weschke in 2010 and is headquartered in Gothenburg, Sweden. | Commercial Services |
SenCere Medical AB
SenCere Medical AB Medical SpecialtiesHealth Technology SenCere Medical is working to prevent the occurrence of pressure ulcers by providing innovative medical devices. SenCere's product development is based on its own clinical research in which the physiological mechanisms of pressure ulcer formation are studied, and the results are used to develop a relief alarm, currently under development. SenCere has completed development of their product, SitSafe. First field test are performed during 2011. SenCere's relief alarm aims to help patients and caregivers prevent the occurrence of pressure ulcers. The company SenCere was founded in 2008 after having been started as a business development project at the Göteborg International Bioscience Business School in 2007. The business was based on an idea and a dissertation made at the then Department of Biomedicine and Surgery at Hälsouniversitetet (the University of Health), and the collaboration between Göteborg and Linköping that emerged. SenCere has evolved from a research project to a company within the Sahlgrenska Science Park incubator. SenCere enters an exciting phase where the company is commencing pilot tests of their prototype with potential customers. The first commercial sale is expected to occur within one year to existing contacts in the health care system. | Health Technology |
Encubator AB
Encubator AB Investment ManagersFinance Part of Chalmers University of Technology Foundation, Encubator AB is an alternative investment manager. The company is based in Gothenburg, Sweden. The Swedish company was founded in 2004. The CEO is Jonas Berggren. | Finance |
